Radius Health Cmn (NASDAQ:RDUS) has grabbed attention from the analysts, when it saw a value increase of 4.01% or 1.37 points in the last trading session to close at $35.54. A total of 2 Million shares exchanged hands during the intra-day trade compared with its average trading volume of 1.14 Million shares, while its relative volume stands at 1.75. Radius Health Cmn (NASDAQ:RDUS) has a market cap of $1.59 Billion and the number of outstanding shares have been calculated 44.72 Million.

Shares of Radius Health Cmn (NASDAQ:RDUS) currently have an Average Brokerage Recommendation of 2.14, number of Recs in ABR is 7 while industry rank of the company by ABR is out of 265. Out of the analyst recommendations 2 rate Radius Health Cmn (NASDAQ:RDUS) stock a Buy, 3 rate the stock Outperform, 2 rate Hold, 0 rate Underperform and 1 recommend a Sell.

Taking a glance at where the stock might be directed in the future, on a consensus basis, the sell-side has a 52 week price target of $61.4 on the stock, this valuation is based on 5 number of opinions. The most optimistic analyst sees the stock reaching $85 while the most conventional has $38 target price.

In order to check on the sell-side rational, we can also take a peek at some technical indicators. Radius Health Cmn (NASDAQ:RDUS)’s price sits -16.38% off from its 50-day moving average of $43.44 and -15.25% away from the stock’s 200-day moving average which is $40.37. Stock’s twelve month price oscillated between $59.88 and $31.58. The stock hit its twelve month high on 08/16/16, and twelve month low on 05/02/17. The Average True Range, a measure of volatility is at 2.23, however its weekly and monthly volatility is 5.76%, 5.48% respectively. The company’s Relative Strength Index which shows price strength currently stands at 33.

Radius Health Cmn (NASDAQ:RDUS) as of recent trade, has shown weekly downbeat performance of -14.96% which was maintained at -26.49% in 1-month period. During the past three months the stock gain 0.06%, bringing six months performance to -18.47%. Yearly performance of the stock shows a bearish trend of -31.11% while year-to-date (YTD) performance reflected -6.55% negative outlook.

While taking a glance at financials, we can look at a number of key indicators. Radius Health Cmn (NASDAQ:RDUS) has trailing twelve month Return on Assets of -71.6%, which is key indicator of how profitable a company is relative to its total assets. The company currently has a Return on Equity of -79.5% and a Return on Investment of 0%. ROI is a performance measure used to evaluate the efficiency of an investment or to compare the efficiency of a number of different investments.

While having a peek at profitability ratios Radius Health Cmn (NASDAQ:RDUS) has trailing twelve month gross margin at 0%, its trailing twelve month operating margin stands at 0% whereas its trailing twelve month net profit margin spots at 0%.

However looking at valuation ratios the stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0. The company’s forward price to earnings ratio for next fiscal year is 0. Radius Health Cmn (NASDAQ:RDUS)’s price to free cash flow for trailing twelve months is 0. Its beta value stands at 0.

The company’s quick ratio for most recent quarter is 7 along with current ratio for most recent quarter of 7. Total debt to equity ratio of the company for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.